Moleculin Biotech (MBRX)
NASDAQ:MBRX
Holding MBRX?
Track your performance easily

Moleculin Biotech (MBRX) Financial Statements

1,337 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently ―. The company's EPS TTM is $-11.661; its P/E ratio is -0.21; Moleculin Biotech is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-2.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 12.00K----
Gross Profit$ 12.00K----
EBIT$ -4.32M$ 8.38M$ -8.92M$ -5.95M$ -5.98M
EBITDA$ -4.29M$ 8.42M$ -8.88M$ -5.92M-
Net Income Common Stockholders$ -4.32M$ -4.97M$ -10.27M$ -5.61M$ -5.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.85M$ 16.82M$ 23.55M$ 24.58M$ 32.17M
Total Assets$ 25.57M$ 30.84M$ 38.22M$ 39.52M$ 47.12M
Total Debt$ 420.00K$ 450.00K$ 474.00K$ 496.00K$ 291.00K
Net Debt$ -10.43M$ -16.37M$ -23.08M$ -24.08M$ -31.88M
Total Liabilities$ 7.87M$ 9.26M$ 12.14M$ 4.38M$ 6.85M
Stockholders Equity$ 17.70M$ 21.59M$ 26.07M$ 35.14M$ 40.27M
Cash Flow-
Free Cash Flow$ -5.96M$ -6.72M$ -5.49M$ -7.58M-
Operating Cash Flow$ -5.95M$ -6.72M$ -5.41M$ -7.55M$ -5.13M
Investing Cash Flow$ -13.00K-$ -81.00K$ -28.00K$ -15.00K
Financing Cash Flow$ -25.00K-$ 4.46M$ -4.00K$ 49.00K
Currency in USD

Moleculin Biotech Earnings and Revenue History

Moleculin Biotech Debt to Assets

Moleculin Biotech Cash Flow

Moleculin Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis